Ironwood Pharmaceuticals, Inc. (IRWD)
3.70
-0.20
(-5.13%)
USD |
NASDAQ |
May 27, 16:00
3.70
0.00 (0.00%)
After-Hours: 17:38
Ironwood Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| AbbVie, Inc. | 919.00M |
| Recursion Pharmaceuticals, Inc. | -3.47M |
| Cytokinetics, Inc. | 7.77M |
| Geron Corp. | 2.425M |
| Gilead Sciences, Inc. | -4.239B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.121M |
| Free Cash Flow | 112.21M |
| Free Cash Flow Per Share (Quarterly) | 0.0307 |
| Free Cash Flow to Equity (Quarterly) | 5.567M |
| Free Cash Flow to Firm (Quarterly) | 10.84M |
| Free Cash Flow Yield | 17.74% |